デフォルト表紙
市場調査レポート
商品コード
1019669

miRNAシーケンスおよびアッセイの市場動向・市場シェア・市場規模の予測 (2021-2028年):製品&サービス・技術・ワークフロー・用途 (癌・自己免疫疾患・統合失調症)・エンドユーザー・地域別

miRNA Sequencing And Assay Market Size, Share & Trends Analysis Report By Product & Service, By Technology, By Workflow, By Application (Cancer, Autoimmune Disease, Schizophrenia), By End-use, By Region, And Segment Forecasts, 2021 - 2028

出版日: | 発行: Grand View Research, Inc. | ページ情報: 英文 136 Pages | 納期: 2-10営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=110.81円
miRNAシーケンスおよびアッセイの市場動向・市場シェア・市場規模の予測 (2021-2028年):製品&サービス・技術・ワークフロー・用途 (癌・自己免疫疾患・統合失調症)・エンドユーザー・地域別
出版日: 2021年07月08日
発行: Grand View Research, Inc.
ページ情報: 英文 136 Pages
納期: 2-10営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界のmiRNAシーケンシングおよびアッセイの市場規模は予測期間中13.0%のCAGRで推移し、2028年には5億9780万米ドルの規模に成長すると予測されています。

医療部門における用途の拡大が大きな成長の可能性を示しています。例えば、いくつかの研究では、癌(乳癌、卵巣癌、子宮頸癌など)、心血管疾患、敗血症、神経系疾患などの診断と予後において、miRNAが効率的なバイオマーカーとして使用できることが示されています。

当レポートでは、世界のmiRNAシーケンシングおよびアッセイの市場を調査し、市場の定義と概要、新型コロナウイルス感染症 (COVID-19) およびその他の市場影響因子の分析、技術動向、市場規模の推移・予測、製品&サービス・技術・ワークフロー・用途・エンドユーザー・地域/主要国など各種区分別の内訳、競合環境、主要企業のプロファイルなどをまとめています。

第1章 調査手法・調査範囲

第2章 エグゼクティブサマリー

第3章 市場可変因子・動向・展望

  • 産業ピラミッドの分析
  • 市場の分類・範囲
  • 市場力学
  • 技術の浸透・成長の見通しマッピング
  • COVID-19:影響分析
  • 事業環境分析
  • 主要な取引・戦略的提携

第4章 市場分析・予測:製品・サービス別

  • 製品
  • サービス

第5章 市場分析・予測:技術別

  • SBS
  • SOLiD
  • ナノポアシーケンシング
  • サンガーシーケンシング
  • 単一分子リアルタイム(SMRT)シーケンシング

第6章 市場分析・予測:ワークフロー別

  • ライブラリー調整
  • シーケンシング
  • データ分析&ストレージ

第7章 市場分析・予測:用途別

  • ポリグルタミン病
  • 自己免疫疾患
  • 統合失調症
  • その他

第8章 市場分析・予測:エンドユーザー別

  • 製薬・バイオテクノロジー産業
  • 研究・学術機関
  • CRO

第9章 市場分析・予測:地域・主要国別

  • 北米
  • 欧州
  • アジア太平洋
  • ラテンアメリカ
  • 中東・アフリカ

第10章 競合情勢

  • 企業の分類
  • 戦略的枠組み
図表

List of Tables

  • Table 1 Oxford Nanopore Technologies Product Comparison
  • Table 2 Comparison of Sanger Sequencing and NGS
  • Table 3 Illumina, Inc. Data Analysis & Storage Informatics Products offering
  • Table 4 MicroRNAs in Autoimmune Diseases
  • Table 5 U.S. miRNA sequencing and assay market, by product & service, 2017 - 2028 (USD Million)
  • Table 6 U.S. miRNA sequencing and assay market, by product, 2017 - 2028 (USD Million)
  • Table 7 U.S. miRNA sequencing and assay market, by technology, 2017 - 2028 (USD Million)
  • Table 8 U.S. miRNA sequencing and assay market, by workflow, 2017 - 2028 (USD Million)
  • Table 9 U.S. miRNA sequencing and assay market, by application, 2017 - 2028 (USD Million)
  • Table 10 U.S. miRNA sequencing and assay market, by end use, 2017 - 2028 (USD Million)
  • Table 11 Canada miRNA sequencing and assay market, by product & service, 2017 - 2028 (USD Million)
  • Table 12 Canada miRNA sequencing and assay market, by product, 2017 - 2028 (USD Million)
  • Table 13 Canada miRNA sequencing and assay market, by technology, 2017 - 2028 (USD Million)
  • Table 14 Canada miRNA sequencing and assay market, by workflow, 2017 - 2028 (USD Million)
  • Table 15 Canada miRNA sequencing and assay market, by application, 2017 - 2028 (USD Million)
  • Table 16 Canada miRNA sequencing and assay market, by end use, 2017 - 2028 (USD Million)
  • Table 17 U.K. miRNA sequencing and assay market, by product & service, 2017 - 2028 (USD Million)
  • Table 18 U.K. miRNA sequencing and assay market, by product, 2017 - 2028 (USD Million)
  • Table 19 U.K. miRNA sequencing and assay market, by technology, 2017 - 2028 (USD Million)
  • Table 20 U.K. miRNA sequencing and assay market, by workflow, 2017 - 2028 (USD Million)
  • Table 21 U.K. miRNA sequencing and assay market, by application, 2017 - 2028 (USD Million)
  • Table 22 U.K. miRNA sequencing and assay market, by end use, 2017 - 2028 (USD Million)
  • Table 23 Germany miRNA sequencing and assay market, by product & service, 2017 - 2028 (USD Million)
  • Table 24 Germany miRNA sequencing and assay market, by product, 2017 - 2028 (USD Million)
  • Table 25 Germany miRNA sequencing and assay market, by technology, 2017 - 2028 (USD Million)
  • Table 26 Germany miRNA sequencing and assay market, by workflow, 2017 - 2028 (USD Million)
  • Table 27 Germany miRNA sequencing and assay market, by application, 2017 - 2028 (USD Million)
  • Table 28 Germany miRNA sequencing and assay market, by end use, 2017 - 2028 (USD Million)
  • Table 29 France miRNA sequencing and assay market, by product & service, 2017 - 2028 (USD Million)
  • Table 30 France miRNA sequencing and assay market, by product, 2017 - 2028 (USD Million)
  • Table 31 France miRNA sequencing and assay market, by technology, 2017 - 2028 (USD Million)
  • Table 32 France miRNA sequencing and assay market, by workflow, 2017 - 2028 (USD Million)
  • Table 33 France miRNA sequencing and assay market, by application, 2017 - 2028 (USD Million)
  • Table 34 France miRNA sequencing and assay market, by end use, 2017 - 2028 (USD Million)
  • Table 35 Italy miRNA sequencing and assay market, by product & service, 2017 - 2028 (USD Million)
  • Table 36 Italy miRNA sequencing and assay market, by product, 2017 - 2028 (USD Million)
  • Table 37 Italy miRNA sequencing and assay market, by technology, 2017 - 2028 (USD Million)
  • Table 38 Italy miRNA sequencing and assay market, by workflow, 2017 - 2028 (USD Million)
  • Table 39 Italy miRNA sequencing and assay market, by application, 2017 - 2028 (USD Million)
  • Table 40 Italy miRNA sequencing and assay market, by end use, 2017 - 2028 (USD Million)
  • Table 41 Spain miRNA sequencing and assay market, by product & service, 2017 - 2028 (USD Million)
  • Table 42 Spain miRNA sequencing and assay market, by product, 2017 - 2028 (USD Million)
  • Table 43 Spain miRNA sequencing and assay market, by technology, 2017 - 2028 (USD Million)
  • Table 44 Spain miRNA sequencing and assay market, by workflow, 2017 - 2028 (USD Million)
  • Table 45 Spain miRNA sequencing and assay market, by application, 2017 - 2028 (USD Million)
  • Table 46 Spain miRNA sequencing and assay market, by end use, 2017 - 2028 (USD Million)
  • Table 48 China miRNA sequencing and assay market, by product & service, 2017 - 2028 (USD Million)
  • Table 49 China miRNA sequencing and assay market, by product, 2017 - 2028 (USD Million)
  • Table 50 China miRNA sequencing and assay market, by technology, 2017 - 2028 (USD Million)
  • Table 51 China miRNA sequencing and assay market, by workflow, 2017 - 2028 (USD Million)
  • Table 52 China miRNA sequencing and assay market, by application, 2017 - 2028 (USD Million)
  • Table 53 China miRNA sequencing and assay market, by end use, 2017 - 2028 (USD Million)
  • Table 54 Japan miRNA sequencing and assay market, by product & service, 2017 - 2028 (USD Million)
  • Table 55 Japan miRNA sequencing and assay market, by product, 2017 - 2028 (USD Million)
  • Table 56 Japan miRNA sequencing and assay market, by technology, 2017 - 2028 (USD Million)
  • Table 57 Japan miRNA sequencing and assay market, by workflow, 2017 - 2028 (USD Million)
  • Table 58 Japan miRNA sequencing and assay market, by application, 2017 - 2028 (USD Million)
  • Table 59 Japan miRNA sequencing and assay market, by end use, 2017 - 2028 (USD Million)
  • Table 60 India miRNA sequencing and assay market, by product & service, 2017 - 2028 (USD Million)
  • Table 61 India miRNA sequencing and assay market, by product, 2017 - 2028 (USD Million)
  • Table 62 India miRNA sequencing and assay market, by technology, 2017 - 2028 (USD Million)
  • Table 63 India miRNA sequencing and assay market, by workflow, 2017 - 2028 (USD Million)
  • Table 64 India miRNA sequencing and assay market, by application, 2017 - 2028 (USD Million)
  • Table 65 India miRNA sequencing and assay market, by end use, 2017 - 2028 (USD Million)
  • Table 66 Australia miRNA sequencing and assay market, by product & service, 2017 - 2028 (USD Million)
  • Table 67 Australia miRNA sequencing and assay market, by product, 2017 - 2028 (USD Million)
  • Table 68 Australia miRNA sequencing and assay market, by technology, 2017 - 2028 (USD Million)
  • Table 69 Australia miRNA sequencing and assay market, by workflow, 2017 - 2028 (USD Million)
  • Table 70 Australia miRNA sequencing and assay market, by application, 2017 - 2028 (USD Million)
  • Table 71 Australia miRNA sequencing and assay market, by end use, 2017 - 2028 (USD Million)
  • Table 72 South Korea miRNA sequencing and assay market, by product & service, 2017 - 2028 (USD Million)
  • Table 73 South Korea miRNA sequencing and assay market, by product, 2017 - 2028 (USD Million)
  • Table 74 South Korea miRNA sequencing and assay market, by technology, 2017 - 2028 (USD Million)
  • Table 75 South Korea miRNA sequencing and assay market, by workflow, 2017 - 2028 (USD Million)
  • Table 76 South Korea miRNA sequencing and assay market, by application, 2017 - 2028 (USD Million)
  • Table 77 South Korea miRNA sequencing and assay market, by end use, 2017 - 2028 (USD Million)
  • Table 78 Brazil miRNA sequencing and assay market, by product & service, 2017 - 2028 (USD Million)
  • Table 79 Brazil miRNA sequencing and assay market, by product, 2017 - 2028 (USD Million)
  • Table 80 Brazil miRNA sequencing and assay market, by technology, 2017 - 2028 (USD Million)
  • Table 81 Brazil miRNA sequencing and assay market, by workflow, 2017 - 2028 (USD Million)
  • Table 82 Brazil miRNA sequencing and assay market, by application, 2017 - 2028 (USD Million)
  • Table 83 Brazil miRNA sequencing and assay market, by end use, 2017 - 2028 (USD Million)
  • Table 84 Mexico miRNA sequencing and assay market, by product & service, 2017 - 2028 (USD Million)
  • Table 85 Mexico miRNA sequencing and assay market, by product, 2017 - 2028 (USD Million)
  • Table 86 Mexico miRNA sequencing and assay market, by technology, 2017 - 2028 (USD Million)
  • Table 87 Mexico miRNA sequencing and assay market, by workflow, 2017 - 2028 (USD Million)
  • Table 88 Mexico miRNA sequencing and assay market, by application, 2017 - 2028 (USD Million)
  • Table 89 Mexico miRNA sequencing and assay market, by end use, 2017 - 2028 (USD Million)
  • Table 91 South Africa miRNA sequencing and assay market, by product & service, 2017 - 2028 (USD Million)
  • Table 92 South Africa miRNA sequencing and assay market, by product, 2017 - 2028 (USD Million)
  • Table 93 South Africa miRNA sequencing and assay market, by technology, 2017 - 2028 (USD Million)
  • Table 94 South Africa miRNA sequencing and assay market, by workflow, 2017 - 2028 (USD Million)
  • Table 95 South Africa miRNA sequencing and assay market, by application, 2017 - 2028 (USD Million)
  • Table 96 South Africa miRNA sequencing and assay market, by end use, 2017 - 2028 (USD Million)
  • Table 97 Saudi Arabia miRNA sequencing and assay market, by product & service, 2017 - 2028 (USD Million)
  • Table 98 Saudi Arabia miRNA sequencing and assay market, by product, 2017 - 2028 (USD Million)
  • Table 99 Saudi Arabia miRNA sequencing and assay market, by technology, 2017 - 2028 (USD Million)
  • Table 100 Saudi Arabia miRNA sequencing and assay market, by workflow, 2017 - 2028 (USD Million)
  • Table 101 Saudi Arabia miRNA sequencing and assay market, by application, 2017 - 2028 (USD Million)
  • Table 102 Saudi Arabia miRNA sequencing and assay market, by end use, 2017 - 2028 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value-chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 Market snapshot, 2020, (USD Million)
  • Fig. 9 Generations of sequencing
  • Fig. 10 Market segmentation & scope
  • Fig. 11 Market trends & outlook
  • Fig. 12 Market driver relevance analysis (Current & future impact)
  • Fig. 13 Advantages of miRNA sequencing
  • Fig. 14 Market restraint analysis
  • Fig. 15 Market opportunity analysis
  • Fig. 16 Market challenge analysis
  • Fig. 17 Penetration & growth prospect mapping for technology, 2020
  • Fig. 18 SWOT analysis, by factor (political & legal, economic and technological)
  • Fig. 19 Porter's Five Forces Analysis
  • Fig. 20 miRNA sequencing and assay market: Product & Services outlook key takeaways
  • Fig. 21 miRNA sequencing and assay market: Product & Services movement analysis
  • Fig. 22 MiRNA Sequencing and Assay Products Market, 2017 - 2028 (USD Million)
  • Fig. 23 Library Preparation Kits Market, 2017 - 2028 (USD Million)
  • Fig. 24 Sequencing Consumables Market, 2017 - 2028 (USD Million)
  • Fig. 25 Instruments market, 2017 - 2028 (USD Million)
  • Fig. 26 MiRNA Sequencing and Assay Services Market, 2017 - 2028 (USD Million)
  • Fig. 27 miRNA sequencing and assay market: Technology outlook key takeaways
  • Fig. 28 miRNA sequencing and assay market: Technology movement analysis
  • Fig. 29 Thermo Fisher Scientific - Small RNA sequencing workflow for Ion Torrent next-generation sequencing systems
  • Fig. 30 Sequencing by Synthesis Market, 2017 - 2028 (USD Million)
  • Fig. 31 Sequencing by Oligonucleotide Ligation and Detection (SOLiD) Market, 2017 - 2028 (USD Million)
  • Fig. 32 Nanopore Sequencing Market, 2017 - 2028 (USD Million)
  • Fig. 33 Sanger Sequencing Market, 2017 - 2028 (USD Million)
  • Fig. 34 Single Molecule Real-time (SMRT) Sequencing Market, 2017 - 2028 (USD Million)
  • Fig. 35 miRNA sequencing and assay market: Workflow outlook key takeaways
  • Fig. 36 miRNA sequencing and assay market: Workflow movement analysis
  • Fig. 37 Library preparation workflow market, 2017 - 2028 (USD Million)
  • Fig. 38 Sequencing Workflow Market, 2017 - 2028 (USD Million)
  • Fig. 39 Data Analysis & Storage Workflow Market, 2017 - 2028 (USD Million)
  • Fig. 40 miRNA sequencing and assay market: Applications outlook key takeaways
  • Fig. 41 miRNA sequencing and assay market: Applications movement analysis
  • Fig. 42 Cancer Market, 2017 - 2028 (USD Million)
  • Fig. 43 Polyglutamine Diseases Market, 2017 - 2028 (USD Million)
  • Fig. 44 Autoimmune Disease Market, 2017 - 2028 (USD Million)
  • Fig. 45 Schizophrenia Market, 2017 - 2028 (USD Million)
  • Fig. 46 Others Market, 2017 - 2028 (USD Million)
  • Fig. 47 miRNA sequencing and assay market: End-use outlook key takeaways
  • Fig. 48 miRNA sequencing and assay market: End-use movement analysis
  • Fig. 49 Pharmaceutical & Biotechnology Industry Market, 2017 - 2028 (USD Million)
  • Fig. 50 Research and Academic Institutes Market, 2017 - 2028 (USD Million)
  • Fig. 51 Contract Research Organizations Market, 2017 - 2028 (USD Million)
  • Fig. 52 Regional marketplace: Key takeaway
  • Fig. 53 MiRNA sequencing & assay market: Regional movement analysis
  • Fig. 54 North America
  • Fig. 55 North America MiRNA sequencing & assay market estimates and forecast, 2017 - 2028 (USD Million)
  • Fig. 56 U.S.
  • Fig. 57 Canada
  • Fig. 58 Europe
  • Fig. 59 Europe MiRNA sequencing & assay market estimates and forecast, 2017 - 2028 (USD Million)
  • Fig. 60 U.K.
  • Fig. 61 Germany
  • Fig. 62 France
  • Fig. 63 Italy
  • Fig. 64 Spain
  • Fig. 65 Asia Pacific
  • Fig. 66 Asia Pacific MiRNA sequencing & assay market estimates and forecast, 2017 - 2028 (USD Million)
  • Fig. 67 China
  • Fig. 68 Japan
  • Fig. 69 India
  • Fig. 70 Australia
  • Fig. 71 South Korea
  • Fig. 72 Latin America
  • Fig. 73 Latin America MiRNA sequencing & assay market estimates and forecast, 2017 - 2028 (USD Million)
  • Fig. 74 Brazil
  • Fig. 75 Mexico
  • Fig. 76 MEA
  • Fig. 77 MEA MiRNA sequencing & assay market estimates and forecast, 2017 - 2028 (USD Million)
  • Fig. 78 South Africa
  • Fig. 79 Saudi Arabia
  • Fig. 80 Company categorization
  • Fig. 81 Strategy framework
目次
Product Code: GVR-4-68039-394-2

miRNA Sequencing And Assay Market Growth & Trends

The global miRNA sequencing and assay market size is expected to reach USD 597.8 million by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 13.0% from 2021 to 2028. Prominent players, such as Illumina, PerkinElmer, Qiagen, and others offer advanced miRNA sequencing products for multiple clinical applications. Moreover, these companies have collaborated with research institutes to expand the application of miRNA sequencing and assay in research studies.

The market holds a significant growth potential owing to the increasing application of miRNA sequencing and assay in the healthcare industry. For instance, several research studies demonstrate that miRNAs can be used as efficient biomarkers in the diagnosis and prognosis of cancer (breast, ovarian, cervical, and others), cardiovascular diseases, sepsis, and nervous system disorders. Therefore, miRNA sequence analysis is increasingly employed to analyze gene regulation in clinical disorders.

As plasma from COVID-19 recovered patients is rich in antiviral miRNAs and antibodies, it has been employed to treat SARS-CoV-2 infected patients. This has led to an increase in research studies that focus on the sequence analysis of miRNAs (microRNA) from the patient as well as the virus.

miRNA Sequencing And Assay Market Report Highlights

The product segment dominated the market and accounted for the largest revenue share in 2020. The commercial presence of multiple players that offer extensive kits, consumables, and instruments for specialized applications contribute to segment growth

Small and mid-sized research entities face financial limitations to install sequencing equipment owing to their high cost. Therefore, these organizations approach service providers. This is expected to drive the services segment with the fastest CAGR over the forecast period

Sequencing by synthesis holds a major share of the technology segment owing to its high sensitivity, fast turnaround time, and high throughput

Additionally, this technology is playing important role in the detection of mutations in tumor tissue which helps to develop targeted and personalized therapies

The sequencing workflow segment held the largest revenue share in 2020 and is expected to witness the fastest CAGR during the forecast period as it is the most important and crucial step of the workflow

The cancer application segment generated the largest revenue share in 2020 owing to ongoing extensive research in cancer using miRNA as a biomarker to study diagnosis and prognosis of cancer and to develop novel therapies

Furthermore, an increase in the number of cancer patients globally drives segment growth

Research and academic institutions are one of the major revenue generators of the market as miRNA sequencing and assay techniques and associated products are being widely used in various research studies conducted by research and academic institutes

In Asia Pacific, the market is anticipated to register a lucrative growth rate throughout the forecast owing to the presence of a huge target population, growing establishment of healthcare, and high unmet clinical needs

Table of Content

Chapter 1 Methodology and Scope

  • 1.1 Research Scope
    • 1.1.1 Estimates and Forecast Timeline
  • 1.2 Research Methodology
  • 1.3 Information Procurement
    • 1.3.1 Purchased Database
    • 1.3.2 GVR's Internal Database
    • 1.3.3 Secondary Sources
      • 1.3.3.1 List of secondary data sources
    • 1.3.4 Primary Research
  • 1.4 Information or Data Analysis
    • 1.4.1 Data Analysis Models
  • 1.5 Market Formulation & Validation
    • 1.5.1 Region-wise market: Base estimates
  • 1.6 Objectives
    • 1.6.1 Objective 1:
    • 1.6.2 Objective 2:

Chapter 2 Executive Summary

  • 2.1 Market Summary

Chapter 3 Market Variables, Trends & Scope

  • 3.1 Industry Pyramid Analysis
    • 3.1.1 Parent & ANCILLARY Market Analysis
  • 3.2 Market Segmentation & Scope
  • 3.3 Market Dynamics
    • 3.3.1 Market driver analysis
      • 3.3.1.1 Advantages of miRNA Sequencing
      • 3.3.1.2 MiRNAs as critical regulators of health and disease
      • 3.3.1.3 Rise in prevalence of cancer and autoimmune disorders
      • 3.3.1.4 Rise in adoption of RNA sequencing protocols in biotechnology research
    • 3.3.2 Market restraint analysis
      • 3.3.2.1 Limitations associated with Bioinformatic Analysis of MicroRNA Sequencing Data
    • 3.3.3 Market opportunity analysis
      • 3.3.3.1 Efforts taken to optimize miRNA-seq data processing
    • 3.3.4 Market challenge analysis
      • 3.3.4.1 Challenges associated with the validation and prediction of miRNA targetome
  • 3.4 Penetration & Growth Prospect Mapping for Technology, 2020
  • 3.5 COVID-19 Impact Analysis on Market
  • 3.6 BUSINESS ENVIRONMENT ANALYSIS
    • 3.6.1 MiRNA sequencing and assay Market - SWOT Analysis, by Factor (Political & Legal, Economic, and Technological)
    • 3.6.2 Porter's Five Forces Analysis
  • 3.7 Major Deals & Strategic Alliances Analysis
    • 3.7.1 Product developments
    • 3.7.2 Merger & acquisition
    • 3.7.3 Agreement
    • 3.7.4 Collaboration & partnership

Chapter 4 Product & Service Business Analysis

  • 4.1 miRNA sequencing and assay market: Product & Services Movement Analysis, 2020 & 2028
  • 4.2 Products
    • 4.2.1 MiRNA Sequencing and Assay Products Market, 2017 - 2028 (USD Million)
    • 4.2.2 Library Preparation Kits
      • 4.2.2.1 Library Preparation Kits market, 2017 - 2028 (USD Million)
    • 4.2.3 Sequencing Consumables
      • 4.2.3.1 Sequencing Consumables market, 2017 - 2028 (USD Million)
    • 4.2.4 Instruments
      • 4.2.4.1 Instruments market, 2017 - 2028 (USD Million)
  • 4.3 Services
    • 4.3.1 MiRNA Sequencing and Assay Services Market, 2017 - 2028 (USD Million)

Chapter 5 Technology Business Analysis

  • 5.1 miRNA sequencing and assay market: Technology Movement Analysis, 2020 & 2028
  • 5.2 Sequencing by Synthesis
    • 5.2.1 Sequencing By Synthesis Market, 2017 - 2028 (USD Million)
  • 5.3 Sequencing by Oligonucleotide Ligation and Detection (SOLiD)
    • 5.3.1 Sequencing By Oligonucleotide Ligation and Detection (SOLiD) Market, 2017 - 2028 (USD Million)
  • 5.4 Nanopore Sequencing
    • 5.4.1 Nanopore Sequencing Market, 2017 - 2028 (USD Million)
  • 5.5 Sanger Sequencing
    • 5.5.1 Sanger Sequencing Market, 2017 - 2028 (USD Million)
  • 5.6 Single Molecule Real-time (SMRT) Sequencing
    • 5.6.1 Single Molecule Real-time (SMRT) Sequencing Market, 2017 - 2028 (USD Million)

Chapter 6 Workflow Business Analysis

  • 6.1 miRNA Sequencing and Assay Market: Workflow Movement Analysis, 2020 & 2028
  • 6.2 Library Preparation
    • 6.2.1 Library Preparation Workflow Market, 2017 - 2028 (USD Million)
  • 6.3 Sequencing
    • 6.3.1 Sequencing Workflow Market, 2017 - 2028 (USD Million)
  • 6.4 Data Analysis & Storage
    • 6.4.1 Data Analysis & Storage Workflow Market, 2017 - 2028 (USD Million)

Chapter 7 Application Business Analysis

  • 7.1 miRNA Sequencing And Assay Market: Applications Movement Analysis, 2020 & 2028
  • 7.2 Cancer
    • 7.2.1 Cancer Market, 2017 - 2028 (USD Million)
  • 7.3 Polyglutamine Diseases
    • 7.3.1 Polyglutamine Diseases Market, 2017 - 2028 (USD Million)
  • 7.4 Autoimmune Disease
    • 7.4.1 Autoimmune Disease Market, 2017 - 2028 (USD Million)
  • 7.5 Schizophrenia
    • 7.5.1 Schizophrenia Market, 2017 - 2028 (USD Million)
  • 7.6 Others
    • 7.6.1 Others Market, 2017 - 2028 (USD Million)

Chapter 8 End-use Business Analysis

  • 8.1 miRNA Sequencing And Assay Market: End-use Movement Analysis, 2020 & 2028
  • 8.2 Pharmaceutical & Biotechnology Industry
    • 8.2.1 Pharmaceutical & Biotechnology Industry Market, 2017 - 2028 (USD Million)
  • 8.3 Research and Academic Institutes
    • 8.3.1 Research and Academic Institutes Market, 2017 - 2028 (USD Million)
  • 8.4 Contract Research Organizations
    • 8.4.1 Contract Research Organizations Market, 2017 - 2028 (USD Million)

Chapter 9 Regional Business Analysis

  • 9.1 MiRNA Sequencing & Assay Market Share By Region, 2020 & 2028
  • 9.2 North America
    • 9.2.1 North America MiRNA sequencing & assay market estimates and forecast, 2017 - 2028 (USD Million)
    • 9.2.2 U.S.
      • 9.2.2.1 U.S. miRNA sequencing and assay market, by product & service, 2017 - 2028 (USD Million)
      • 9.2.2.2 U.S. miRNA sequencing and assay market, by technology, 2017 - 2028 (USD Million)
      • 9.2.2.3 U.S. miRNA sequencing and assay market, by workflow, 2017 - 2028 (USD Million)
      • 9.2.2.4 U.S. miRNA sequencing and assay market, by application, 2017 - 2028 (USD Million)
      • 9.2.2.5 U.S. miRNA sequencing and assay market, by end use, 2017 - 2028 (USD Million)
    • 9.2.3 Canada
      • 9.2.3.1 Canada miRNA sequencing and assay market, by product & service, 2017 - 2028 (USD Million)
      • 9.2.3.2 Canada miRNA sequencing and assay market, by technology, 2017 - 2028 (USD Million)
      • 9.2.3.3 Canada miRNA sequencing and assay market, by workflow, 2017 - 2028 (USD Million)
      • 9.2.3.4 Canada miRNA sequencing and assay market, by application, 2017 - 2028 (USD Million)
      • 9.2.3.5 Canada miRNA sequencing and assay market, by end use, 2017 - 2028 (USD Million)
  • 9.3 Europe
    • 9.3.1 Europe MiRNA sequencing & assay market estimates and forecast, 2017 - 2028 (USD Million)
    • 9.3.2 U.K.
      • 9.3.2.1 U.K. miRNA sequencing and assay market, by product & service, 2017 - 2028 (USD Million)
      • 9.3.2.2 U.K. miRNA sequencing and assay market, by technology, 2017 - 2028 (USD Million)
      • 9.3.2.3 U.K. miRNA sequencing and assay market, by workflow, 2017 - 2028 (USD Million)
      • 9.3.2.4 U.K. miRNA sequencing and assay market, by application, 2017 - 2028 (USD Million)
      • 9.3.2.5 U.K. miRNA sequencing and assay market, by end use, 2017 - 2028 (USD Million)
    • 9.3.3 Germany
      • 9.3.3.1 Germany miRNA sequencing and assay market, by product & service, 2017 - 2028 (USD Million)
      • 9.3.3.2 Germany miRNA sequencing and assay market, by technology, 2017 - 2028 (USD Million)
      • 9.3.3.3 Germany miRNA sequencing and assay market, by workflow, 2017 - 2028 (USD Million)
      • 9.3.3.4 Germany miRNA sequencing and assay market, by application, 2017 - 2028 (USD Million)
      • 9.3.3.5 Germany miRNA sequencing and assay market, by end use, 2017 - 2028 (USD Million)
    • 9.3.4 France
      • 9.3.4.1 France miRNA sequencing and assay market, by product & service, 2017 - 2028 (USD Million)
      • 9.3.4.2 France miRNA sequencing and assay market, by technology, 2017 - 2028 (USD Million)
      • 9.3.4.3 France miRNA sequencing and assay market, by workflow, 2017 - 2028 (USD Million)
      • 9.3.4.4 France miRNA sequencing and assay market, by application, 2017 - 2028 (USD Million)
      • 9.3.4.5 France miRNA sequencing and assay market, by end use, 2017 - 2028 (USD Million)
    • 9.3.5 Italy
      • 9.3.5.1 Italy miRNA sequencing and assay market, by product & service, 2017 - 2028 (USD Million)
      • 9.3.5.2 Italy miRNA sequencing and assay market, by technology, 2017 - 2028 (USD Million)
      • 9.3.5.3 Italy miRNA sequencing and assay market, by workflow, 2017 - 2028 (USD Million)
      • 9.3.5.4 Italy miRNA sequencing and assay market, by application, 2017 - 2028 (USD Million)
      • 9.3.5.5 Italy miRNA sequencing and assay market, by end use, 2017 - 2028 (USD Million)
    • 9.3.6 Spain
      • 9.3.6.1 Spain miRNA sequencing and assay market, by product & service, 2017 - 2028 (USD Million)
      • 9.3.6.2 Spain miRNA sequencing and assay market, by technology, 2017 - 2028 (USD Million)
      • 9.3.6.3 Spain miRNA sequencing and assay market, by workflow, 2017 - 2028 (USD Million)
      • 9.3.6.4 Spain miRNA sequencing and assay market, by application, 2017 - 2028 (USD Million)
      • 9.3.6.5 Spain miRNA sequencing and assay market, by end use, 2017 - 2028 (USD Million)
  • 9.4 Asia Pacific
    • 9.4.1 Asia Pacific MiRNA sequencing & assay market estimates and forecast, 2017 - 2028 (USD Million)
    • 9.4.2 China
      • 9.4.2.1 China miRNA sequencing and assay market, by product & service, 2017 - 2028 (USD Million)
      • 9.4.2.2 China miRNA sequencing and assay market, by technology, 2017 - 2028 (USD Million)
      • 9.4.2.3 China miRNA sequencing and assay market, by workflow, 2017 - 2028 (USD Million)
      • 9.4.2.4 China miRNA sequencing and assay market, by application, 2017 - 2028 (USD Million)
      • 9.4.2.5 China miRNA sequencing and assay market, by end use, 2017 - 2028 (USD Million)
    • 9.4.3 Japan
      • 9.4.3.1 Japan miRNA sequencing and assay market, by product & service, 2017 - 2028 (USD Million)
      • 9.4.3.2 Japan miRNA sequencing and assay market, by technology, 2017 - 2028 (USD Million)
      • 9.4.3.3 Japan miRNA sequencing and assay market, by workflow, 2017 - 2028 (USD Million)
      • 9.4.3.4 Japan miRNA sequencing and assay market, by application, 2017 - 2028 (USD Million)
      • 9.4.3.5 Japan miRNA sequencing and assay market, by end use, 2017 - 2028 (USD Million)
    • 9.4.4 India
      • 9.4.4.1 India miRNA sequencing and assay market, by product & service, 2017 - 2028 (USD Million)
      • 9.4.4.2 India miRNA sequencing and assay market, by technology, 2017 - 2028 (USD Million)
      • 9.4.4.3 India miRNA sequencing and assay market, by workflow, 2017 - 2028 (USD Million)
      • 9.4.4.4 India miRNA sequencing and assay market, by application, 2017 - 2028 (USD Million)
      • 9.4.4.5 India miRNA sequencing and assay market, by end use, 2017 - 2028 (USD Million)
    • 9.4.5 Australia
      • 9.4.5.1 Australia miRNA sequencing and assay market, by product & service, 2017 - 2028 (USD Million)
      • 9.4.5.2 Australia miRNA sequencing and assay market, by technology, 2017 - 2028 (USD Million)
      • 9.4.5.3 Australia miRNA sequencing and assay market, by workflow, 2017 - 2028 (USD Million)
      • 9.4.5.4 Australia miRNA sequencing and assay market, by application, 2017 - 2028 (USD Million)
      • 9.4.5.5 Australia miRNA sequencing and assay market, by end use, 2017 - 2028 (USD Million)
    • 9.4.6 South Korea
      • 9.4.6.1 South Korea miRNA sequencing and assay market, by product & service, 2017 - 2028 (USD Million)
      • 9.4.6.2 South Korea miRNA sequencing and assay market, by technology, 2017 - 2028 (USD Million)
      • 9.4.6.3 South Korea miRNA sequencing and assay market, by workflow, 2017 - 2028 (USD Million)
      • 9.4.6.4 South Korea miRNA sequencing and assay market, by application, 2017 - 2028 (USD Million)
      • 9.4.6.5 South Korea miRNA sequencing and assay market, by end use, 2017 - 2028 (USD Million)
  • 9.5 Latin America
    • 9.5.1 Latin America MiRNA sequencing & assay market estimates and forecast, 2017 - 2028 (USD Million)
    • 9.5.2 Brazil
      • 9.5.2.1 Brazil miRNA sequencing and assay market, by product & service, 2017 - 2028 (USD Million)
      • 9.5.2.2 Brazil miRNA sequencing and assay market, by technology, 2017 - 2028 (USD Million)
      • 9.5.2.3 Brazil miRNA sequencing and assay market, by workflow, 2017 - 2028 (USD Million)
      • 9.5.2.4 Brazil miRNA sequencing and assay market, by application, 2017 - 2028 (USD Million)
      • 9.5.2.5 Brazil miRNA sequencing and assay market, by end use, 2017 - 2028 (USD Million)
    • 9.5.3 Mexico
      • 9.5.3.1 Mexico miRNA sequencing and assay market, by product & service, 2017 - 2028 (USD Million)
      • 9.5.3.2 Mexico miRNA sequencing and assay market, by technology, 2017 - 2028 (USD Million)
      • 9.5.3.3 Mexico miRNA sequencing and assay market, by workflow, 2017 - 2028 (USD Million)
      • 9.5.3.4 Mexico miRNA sequencing and assay market, by application, 2017 - 2028 (USD Million)
      • 9.5.3.5 Mexico miRNA sequencing and assay market, by end use, 2017 - 2028 (USD Million)
  • 9.6 MEA
    • 9.6.1 MEA MiRNA sequencing & assay market estimates and forecast, 2017 - 2028 (USD Million)
    • 9.6.2 South Africa
      • 9.6.2.1 South Africa miRNA sequencing and assay market, by product & service, 2017 - 2028 (USD Million)
      • 9.6.2.2 South Africa miRNA sequencing and assay market, by technology, 2017 - 2028 (USD Million)
      • 9.6.2.3 South Africa miRNA sequencing and assay market, by workflow, 2017 - 2028 (USD Million)
      • 9.6.2.4 South Africa miRNA sequencing and assay market, by application, 2017 - 2028 (USD Million)
      • 9.6.2.5 South Africa miRNA sequencing and assay market, by end use, 2017 - 2028 (USD Million)
    • 9.6.3 Saudi Arabia
      • 9.6.3.1 Saudi Arabia miRNA sequencing and assay market, by product & service, 2017 - 2028 (USD Million)
      • 9.6.3.2 Saudi Arabia miRNA sequencing and assay market, by technology, 2017 - 2028 (USD Million)
      • 9.6.3.3 Saudi Arabia miRNA sequencing and assay market, by workflow, 2017 - 2028 (USD Million)
      • 9.6.3.4 Saudi Arabia miRNA sequencing and assay market, by application, 2017 - 2028 (USD Million)
      • 9.6.3.5 Saudi Arabia miRNA sequencing and assay market, by end use, 2017 - 2028 (USD Million)

Chapter 10 COMPETITIVE LANDSCAPE

  • 10.1 Company categorization
  • 10.2 Strategy framework
    • 10.2.1 Thermo Fisher Scientific, Inc.
      • 10.2.1.1 Company overview
      • 10.2.1.2 Financial performance
      • 10.2.1.3 Product benchmarking
      • 10.2.1.4 Strategic initiatives
    • 10.2.2 Illumina, Inc.
      • 10.2.2.1 Company overview
      • 10.2.2.2 Financial Performance
      • 10.2.2.3 Product benchmarking
    • 10.2.3 QIAGEN
      • 10.2.3.1 Company overview
      • 10.2.3.2 Financial Performance
      • 10.2.3.3 Product benchmarking
    • 10.2.4 PerkinElmer, Inc.
      • 10.2.4.1 Company overview
      • 10.2.4.2 Financial Performance
      • 10.2.4.3 Product benchmarking
    • 10.2.5 Abcam plc
      • 10.2.5.1 Company overview
      • 10.2.5.2 Financial Performance
      • 10.2.5.3 Product benchmarking
    • 10.2.6 New England Biolabs
      • 10.2.6.1 Company overview
      • 10.2.6.2 Financial Performance
      • 10.2.6.3 Product benchmarking
    • 10.2.7 Takara Bio Inc.
      • 10.2.7.1 Company overview
      • 10.2.7.2 Financial Performance
      • 10.2.7.3 Product benchmarking
      • 10.2.7.4 Strategic initiatives
    • 10.2.8 Lexogen GmbH
      • 10.2.8.1 Company overview
      • 10.2.8.2 Financial Performance
      • 10.2.8.3 Product benchmarking
      • 10.2.8.4 Strategic initiatives
    • 10.2.9 Norgen Biotek Corp.
      • 10.2.9.1 Company overview
      • 10.2.9.2 Financial Performance
      • 10.2.9.3 Product benchmarking
      • 10.2.9.4 Strategic initiatives
    • 10.2.10 Maravai LifeSciences
      • 10.2.10.1 Company overview
      • 10.2.10.1.1 TriLink BioTechnologies
      • 10.2.10.2 Financial Performance
      • 10.2.10.3 Product benchmarking
      • 10.2.10.4 Strategic initiatives
    • 10.2.11 HTG Molecular Diagnostics, Inc.
      • 10.2.11.1 Company overview
      • 10.2.11.2 Financial performance
      • 10.2.11.3 Product benchmarking
      • 10.2.11.4 Strategic initiatives
    • 10.2.12 Meridian Bioscience, Inc.
      • 10.2.12.1 Company overview
      • 10.2.12.2 Financial performance
      • 10.2.12.3 Product benchmarking
      • 10.2.12.4 Strategic initiatives
    • 10.2.13 System Biosciences, LLC.
      • 10.2.13.1 Company overview
      • 10.2.13.2 Financial Performance
      • 10.2.13.3 Product benchmarking